This application seeks continued funding for a period of five years for the Cancer Center Support Grant of the University of Southern California Comprehensive Cancer Center. The USC Comprehensive Cancer Center is a separately defined component of the USC School of Medicine. The Center pursues excellence in cancer research, treatment and education through collaborative relationships among its members and with the community. The Cancer Center Program is divided into three divisions, each with a number of program areas; Basic Research; Clinical Investigations; and Cancer Cause and Prevention. The objective of the basic research program areas is to promote interdisciplinary studies on the causes and mechanisms of cancer development and spread through research in virology, cell and molecular biology, chemical carcinogenesis, experimental immunology, and cancer pharmacology, The clinical programs conduct research on effective new methods for cancer diagnosis and management and aim to provide the best possible care for cancer patients at the Norris Cancer Hospital, the LAC-USC Medical Center, the Childrens Hospital of Los Angeles, and the other hospitals affiliated with the Center. The programs in cancer cause and prevention conduct hypothesis based studies of the occurrence of cancer in human populations; develop and apply statistical methods to improve the quality of epidemiological studies and clinical trials; and to design and carry out multidisciplinary studies of methods of cancer prevention, cancer screening, treatment compliance, and patient adaptations to cancer and its treatment. The Cancer Center also actively promotes the education and training of basic scientists, clinicians, clinical investigators, and allied health personnel who deal with cancer. Funds are requested to support the senior leadership, the program coordinators, the administration, the shared facilities and resources, and the continued development of USC Cancer Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014089-15
Application #
3101384
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1980-04-01
Project End
1990-11-30
Budget Start
1989-12-01
Budget End
1990-11-30
Support Year
15
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Neumeyer, Sonja; Banbury, Barbara L; Arndt, Volker et al. (2018) Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer 118:1639-1647
Basso, Virginia; Garcia, Angie; Tran, Dat Q et al. (2018) Fungicidal Potency and Mechanisms of ?-Defensins against Multidrug-Resistant Candida Species. Antimicrob Agents Chemother 62:
Austria, Theresa; Marion, Christine; Yu, Vanessa et al. (2018) Mechanism of cytokinesis failure in ovarian cystadenomas with defective BRCA1 and P53 pathways. Int J Cancer 143:2932-2942
Ning, Y; Zhang, W; Hanna, D L et al. (2018) Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients. Pharmacogenomics J 18:29-34
Battaglin, Francesca; Naseem, Madiha; Puccini, Alberto et al. (2018) Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions. Cancer Cell Int 18:99
Zhang, Junjie; Zhao, Jun; Xu, Simin et al. (2018) Species-Specific Deamidation of cGAS by Herpes Simplex Virus UL37 Protein Facilitates Viral Replication. Cell Host Microbe 24:234-248.e5
Eriguchi, Yoshihiro; Nakamura, Kiminori; Yokoi, Yuki et al. (2018) Essential role of IFN-? in T cell-associated intestinal inflammation. JCI Insight 3:
Thomas, Nancy E; Edmiston, Sharon N; Orlow, Irene et al. (2018) Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes. J Invest Dermatol 138:2398-2404
Cobo, Eduardo R; Holani, Ravi; Moreau, France et al. (2018) Entamoeba histolytica Alters ileal Paneth Cell Functions in Intact and Muc2 Mucin Deficiency. Infect Immun :
Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu et al. (2018) Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib. Clin Colorectal Cancer 17:e395-e414

Showing the most recent 10 out of 842 publications